GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Endocyte, Inc. (ECYT) [hlAlert]

Endocyte, Inc. (Endocyte) is a biopharmaceutical company. The Company is engaged in developing therapies for the treatment of cancer and inflammatory diseases. Endocyte uses its technology to create small molecule drug conjugates (SMDCs), and companion imaging diagnostics. Its SMDCs target receptors that are over-expressed on
diseased cells, primarily to healthy cells. The Company?s SMDCs consists of three modules: a targeting ligand, a linker and a drug payload. The foundation of its technology is its small molecule targeting ligands, which bind to over-expressed receptors on target cells, while avoiding healthy cells. It is developing a number of different targeting ligands for a range of cancers and inflammatory diseases. Its linker system attaches the targeting ligand to the drug payload. The drug payload is the biologically active component of its SMDCs. Endocyte?s core SMDC, EC145, targets the folate receptor.
( Total: 8 Current Stock Recommendations )
Endocyte, Inc.   (8)
Hold 25% Buy 75%
Related companies
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Nutraceutical ...   (1)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
9/30/2013  
Buy
  
9/30/2014  
Hold
  
11/20/2012  
Buy
  
12/21/2012  
Buy
  
2/18/2013  
Buy
  
5/2/2014  
Hold
  
3/21/2014  
Buy
  
3/21/2014  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy